1
Company Presentation
Ownership and stock price
5.2% performance difference as of September 5th, 2013Ownership structure (Jun-13)
Market Cap (MMUS$)
Stock price (Ch$)
Net Income 1H13 (US$* Th)
1,248
6,328
58,938
P/E
10.8
P/BV
1.4
September 5
th2013
-15.5% -10.4%Evolution of the stock price
Dividend Pay Out
60%-80%
*Exchange rate of Ch$507.16 as of June 30th, 2013
CChC 67,0% Internationals 14,7% Stockbrokers 12,4%
Mutual Funds & Others 5,9% -30% -20% -10% 00% 10% 20% 30% 40%
jul-12 ago-12 sep-12 oct-12 nov-12 dic-12 ene-13 feb-13 mar-13 abr-13 may-13 jun-13 jul-13 ago-13
3
ILC
Page
3
June, 2013
Exchange rate: CLP 507.16 per 1USD (*) Since June 18th, 2013
Pension funds administration (AFP)
Retirement
Sector
Health insurance institution (ISAPRE)
Hospital healthcare services
Outpatient healthcare services
Supplemental health insurance
Healthcare
and life
Insurance
Sector
Network of nine private schools and one
subsidized private school
IT and outsourcing services
Other
Business
US$125.3 mm
RevenuesUS$ 23.2 mm
US$ 73.8 mm
Net IncomeUS$ 0.3 mm
67.5%
Ownership99.9%
US$156.7 mm
US$ 180.4
mm
US$ 9,6 mm
US$ 5.5 mm
99.9%
89.9%
US$ 14.5 mm
US$ 0.37 mm
49.0%*
32.9%
Company overview
Revenues come from…
Gross
Salary
Net
Salary
Taxes: Range 0% - 40%
$
1.27% Commission feeSupplemental health insurance
7%
Additional health contribution
Mandatory
Voluntary
Pension Fund
Health insurance
Healthcare
Habitat average: Ch$ 607.691
(US$ 1.198
)
Chile average: Ch$ 569.077
(US$ 1.112)
Gross Salary
Source: Superintendencia AFP, as of June-13; exchange rate $507.16
10%
5
Our Business
Habitat
Income Statement (Th.US$*)
Revenues Cost of sales Jun – 13 125,274 -EBITDAE** SG&A 83,717 (50,906) Operating Income 74,192 Gross Profit 125,274 Jun – 12 121,887 -91,297 (40,731) 81,019 121,887 Net Income 73,829 81,213 Var. % 2.8% --8.3% 25.0% -8.4% 2.8% -9.1%Gain (loss) of the encaje 7,540 11,087 -32.0%
•
Created in 1981 under the new
provisional system
•
The only AFP under the same
controller over it history
•
67.5% owned by ILC
•
The most efficient AFP in terms
of cost control and the second
cheapest on fees
**EBITDAE calculated as profit before tax minus depreciation, finance cost, other non operational cost and financial income due to Habitat´s encaje. * Exchange rate of Ch$507.16 as of June 30th,2013.
7
ILC
Page
7
1,756,717 1,231,266 1,056,594 527,513 476,072 187,939 0 500,000 1,000,000 1,500,000 2,000,000PROVIDA HABITAT CAPITAL MODELO CUPRUM PLANVITAL
Habitat: Key considerations
Salary base increase
Voluntary savings products
Incorporation of independent workers to the system
Capture of transfers from competitors
Products offered
Mandatory individual capitalization account
Contributions = 10% of gross salary (capped at
~US$3,000 per month)
Voluntary pension contributions
Tax exempt, up to a certain amount
Voluntary savings account
Allows withdrawals at any time
Programmed withdrawals
Pension payment option in which retirees maintain
their account with the AFP
Ample growth opportunities
Total AUM = US$157.8 bn
Source: Superintendencia de Pensiones, as of July 31st, 2013Contributors market share (as of June 2013)
Source: Superintedencia de Pensiones
1Contributors / affiliates Contribution rate1 51.8% 57.7% 56.6% 50.0% 76.0% 47.9% Habitat 26.2% Cuprum 20.6% Capital 21.4% Planvital 2.8% Provida 28.0% Modelo 1.0%
Net Income (Ch$ mm)
48,615 55,974 63,500 61,515 35,565 33,619 27,089 19,504 13,061 5,623 3,824 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 2009 2010 2011 2012 Jun-12 Jun-13Fee income
(US$ million)& Expenses % (Mar – 2013)
Current mandatory fee (Dec – 2012)
Operating expenses & % fee income (Mar-13)
Habitat: Key considerations
Based on actual figures Adjusted to Habitat’s 1.27% fee rate Habitat 1.27% Capital 1.44% Cuprum 1.48% Provida 1.54% Planvital 2.36% Modelo 0.77% 10 20 30 40 50 60 20% 40% 60% 80% 100% F e e I n c o m e ( U S $ m ill io n )
Expenses % Fee Income
Habitat 65.36 Capital 59.9 Cuprum 51.5 Provida 86.3 Planvital 11.7 Modelo 9.3 34.5% 35.7% 43.8% 23.7% 55.3% 59.6% 70 80 90
CAGR ex-encaje (‘09-’12) 8.2%
(1,846)9
ILC
Page
9
30,793 36,305 37,281 41,805 41,413 30,000 32,000 34,000 36,000 38,000 40,000 42,000 44,000 2009 2010 2011 2012 Jun-13Habitat: Operating Data
Assets under management
Contributor average salary
Evolution of Habitat AUM (US$ Million)
CAGR: 8.8%
Source: Superintendencia de Pensiones, as of June 30, 2013 3,166,995 3,806,148 7,896,648 2,849,505 3,147,208 0 2000000 4000000 6000000 8000000 10000000 Fund type A Fund type B Fund type C Fund type D Fund type E Ch$ million 429,034 442,013 471,108 507,869 547,553 569,077 429,414 442,068 475,543 523,877 578,907 607,691 400000 450000 500000 550000 600000 650000
Dec 08 Dec 09 Dec 10 Dec 11 Dec-12 Jun-13 Industry Habitat
Perú
The
peruvian
market
presents
ample
growth oportunities, due to the level of
development
and
the
political
and
economic stability
Source: IMF
Source: IMF
Source: Instituto Nacional de Estadísticas e Informática de Perú
CAC: 7.2%
CAC: 1,1%
GDP per capita (PPP)
US$
Unemployment rate
% of the labor forceEstimated population
Million people11
ILC
Page 11
1,471,296 1,419,541 1,350,653 1,151,360 30,000 230,000 430,000 630,000 830,000 1,030,000 1,230,000 1,430,000 1,630,000Prima Horizonte Integra Profuturo
Habitat: Peru
December 20
th, 2012, Habitat was awarded in the first auction in
Peru
All the new entrant into the formal sector contribute into Habitat
for two years
600,000 new beneficiaries expected in two years
As of June 1
st2013, Habitat started operations in Peru.
As of July 31
st2013, Habitat Peru had more than 12,000 affiliates
Mandatory mix fee rate after the first auction (%)
Ample growth opportunities
Total AUM = US$36 bn
Source: SBS as of May, 2013Contributors market share (as of May 2013)
Prima
1,55% Over the contribution
Integra
Over the AUM
1,51% Horizonte 1,49% Profuturo 1,65% PROMEDIO 0,47% Habitat 1,33% 1,20% 1,90% 1,20% 1,40% 1,25% 1,39%
Source: Superintendencia de Banca, Seguros y AFP del Perú Source: SBS as of May 2013 (**) On April 2013
50% Integra 50% Profuturo ** Horizonte 23.7% Integra 29.9% Prima 31.2% Profuturo 15.1%
Potential synergies in the health business
7% of the
gross salary
is the
mandatory
contribution
*The GES plan cost 0.164 U.F
** The GES plan will cost 0.325 U.F since July 1st, 2013
USD 7.7*
Full coverage of 69 diseases in a established network10% of the
gross salary
is the average
contribution
Average monthly contribution
per contributor: USD $135.1
Medical Bill
Monthly primus
Co-payment between the company and the employee
Average monthly contribution
per beneficiary: USD $18.7
% covered by:
% covered by:
% of the
Net Salary
% covered by the
person
or
Full coverage of 11 new diseases**USD 15.2**
13
ILC
Page 13
Consalud
Jun – 13 293,526 (251,638) (40,113) 4,045 41,889 Jun – 12 265,352 (216,473) (35,955) 13,649 48,879 5,705 12,176 Var. % 10.6% 16.2% 11.6% -70.4% -14.3% -53.1%Income Statement (Th. US$*)
Revenues Cost of sales SG&A Operating Income Gross Margin Net Income•
Created in 1984 under the new
provisional
health
system
(Isapre).
•
99.9% owned by ILC.
•
The price of GES will rise to UF
0.325 due to the inclusion of 11
new diseases, since July 1
st
,
2013.
8,507 17,279 -50.8%
EBITDA**
**EBITDA calculated as profit before tax minus depreciation, finance cost and other non operational cost. *Exchange rate of Ch$507.16 as of June 30th,2013.
Products offered
Consalud: Key considerations
Growing demand prospects
Leading private health insurance provider
and strong market position
Strong brand recognition
Continuous innovation and incorporation of
new technologies
First choice provider for people moving
from the public to the private health
insurance system
Medical plans
Open network plans
Preferred provider plans
Closed network plans
Complementary product offerings
Additional coverage for catastrophic
diseases
Dental plans
Pharmacy plans
18.6% 18.2% 13.6% 29.8% 19.7% Isapre: 3.06 mm Fonasa D: 3.0 mm Fonasa C: 2.2 mm Fonasa B: 4.9 mm Fonasa A: 3.2 mmSource: Superintendencia de Salud, as of June, 2013 Others includes Vida Tres and Ferrosalud.
Total Contributors = 1,638,988
Source: Fonasa, as of December, 2012
Consalud 22.3% Cruz Blanca 20.9% Banmédica 20.8% Colmena 15.9% Masvida 14.7% Others 5.4%
15
ILC
Page 15
Consalud: Key considerations
Source: Superintedencia de Salud and ILC 1Operating revenues divided by the number of contributors. Exchange rate of Ch$507.16 as of June 30th,2013; 2Operating expenses divided by operating
revenues
Number of Contributors (as of June 2013)
Average monthly contribution
1in US$ (Jun-13 LTM)
Loss ratio
2(Jun-13 LTM)
Number of Beneficiaries (as of June 2013)
366,178 343,075 341,289 260,291 240,122 74,143 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000
Consalud Cruz Blanca Banmédica Colmena Masvida Vida Tres
689,029 633,770 632,305 478,298 451,918 138,966 0 100,000 200,000 300,000 400,000 500,000 600,000 700,000 800,000
Consalud Banmédica Cruz Blanca Colmena Masvida Vida Tres
83.3% 84.2% 84.9% 85.5% 86.3% 87.6% 81.0% 82.0% 83.0% 84.0% 85.0% 86.0% 87.0% 88.0%
Colmena Vida Tres Consalud Banmédica Masvida Cruz Blanca 130.0 152.1 166.8 172.4 206.9 247.8 0 50 100 150 200 250 300
Consalud: Operating data
Mandatory contributions (Ch$ million) Voluntary contributions (Ch$ million)
Dec- 11
182,697 62,748 TOTAL (Ch$ million) 248,798 Others (Ch$ million) 3,353Dec-12
208,126 66,793 275,380 461 Jun-13 (LTM) 219,999 69,314 310,268 357Source: Superintedencia de Salud.
639,776 671,571 689,029 388,882 410,053 420,402 370000 375000 380000 385000 390000 395000 400000 405000 410000 415000 420000 425000 610000 620000 630000 640000 650000 660000 670000 680000 690000 700000
Dic-11 Dic-12 Jun-13 (LTM)
Beneficiaries
N° Beneficiaries Revenues / Beneficiary
17
ILC
Page 17
Red Salud
June – 13 180,403 (142,505) (25,440) 12,458 37,898 June – 12 154,498 (119,789) (24,945) 9,764 34,709 5,529 3,548 Var. % 16.8% 19.0% 2.0% 27.6% 9.2% 55.8%Income Statement (Th. US$*)
Revenues Cost of sales SG&A Operating Income Gross Margin Net Income•
One of the main private healthcare
providers, reaching close to 18.5%
of the private beds in Chile.
•
89.9% owned by ILC.
•
National
coverage
through
a
network of 17 hospitals and 32
medical centers.
23,572 20,727 13.7%
EBITDA**
**EBITDA calculated as profit before tax minus depreciation, finance cost and other non operational cost. *Exchange rate of Ch$507.16 as of June 30th,2013.
68
100
103
105
105
128
256
330
335
360
220
540
Iquique
Las Lilas
Avansalud
UC San Carlos
UC Lira
Tabancura
Las Condes
Alemana
Santa María
Indisa
Bicentario
Davila
Chilean private hospitals by number of beds (2012)
Red Salud: Overview
493*
Red Salud hospitals Others
ILC market share (in terms of private
hospital beds): 18,5%
Source: ILC, annual reports of the companies as filed with the SVS, except Clinica Alemana, where the information has been derived from its website; *Represents the original number of beds for this project, still not approve by the board.
19
ILC
Page 19
Evolution of revenues – Red Salud
Red Salud: Operating data
Admissions
Emergency room visits
Jun -12
23,455 52,880 Patient days 57,210Jun -13
25,542 61,271 61,698 Tabancura Avansalud Average ocupancy rate 73.2% 63.0% Iquique 51.3% Bicentenario 66.1% Average lenght of stay (days) 2.92 1.39 2.45 3.06 Jun - 13Includes Bicentenario, Avansalud, Tabancura and Iquique hospitals
Evolution of EBITDA LTM – Clínica Bicentenario
47,816 66,442 72,208 86,122 97,369 104,741 0 20000 40000 60000 80000 100000 120000 140000 160000 180000 200000
Dec-11 Dec-12 Jun-13 (LTM)
Hospital revenues Outpatient revenues Ch$ million -4,881-4,418 -4,096 -3,508-3,061 -2,599-2,273 -1,926-1,331-1,508 -1,427-1,089-634 -594 -533 -168 100 488 740 -6,000 -5,000 -4,000 -3,000 -2,000 -1,000 0 1,000 2,000 d e c -1 1 ja n -1 2 fe b -1 2 m a r-1 2 a p r-1 2 m a y -1 2 ju n -1 2 ju l-1 2 a g o -1 2 s e p -1 2 o c t-1 2 n o v -1 2 d e c -1 2 ja n -1 3 fe b -1 3 m a r-1 3 a p r-1 3 m a y -1 3 ju n -1 3 Ch$ Millions
Red Salud: Operating data
Evolution of Revenues, Net Income and EBITDA of our private
hospitals and outpatient centers
Income Statement (Jun-13)
Megasalud
Avansalud
Tabancura Bicentenario
Iquique
Ch$ millions
Revenues
40,042
15,158
15,321
17,065
3,180
Cost of sales
( 31,150)
( 11,820)
( 11,732)
( 14,866)
( 2,201)
Gross Profit
8,891
3,337
3,589
2,200
980
SG&A
( 5,373)
( 1,822)
( 2,426)
( 1,980)
( 759)
Operating Income
3,518
1,515
1,163
220
220
Net Income
2,560
702
825
( 918)
164
EBITDA
(*)4,995
2,630
1,799
1,203
320
Income Statement (Jun-12)
Megasalud
Avansalud
Tabancura Bicentenario
Iquique
Ch$ millions
Revenues
37,356
11,635
13,817
12,364
3,074
Cost of sales
( 28,447)
( 8,788)
( 10,150)
( 10,996)
( 2,293)
Gross Profit
8,909
2,847
3,667
1,368
781
SG&A
( 5,216)
( 1,540)
( 2,290)
( 2,426)
( 775)
Operating Income
3,692
1,307
1,377
( 1,057)
6
Net Income
2,819
773
967
( 2,589)
( 20)
EBITDA
(*)4,979
2,154
1,926
( 194)
116
21
ILC
Page 21
Vida Cámara
Jun – 13 23,691 (22,025) (5,392) (3,726) 1,666 Jun – 12 173,441 (124,598) (5,525) 43,317 48,842 302 38,686 Var. % (86.3%) (82.3%) (2.4%) (108.6%) (96.6%) (99.2%) Revenues Cost of Sales SG&A Operating Income Gross Margin Net Income•
Created in 2009 due to the
acquisition of 99.9% of RBS
(Chile) Seguros de Vida S.A.
•
99.9% owned by ILC
•
Until June 2012 was focus in
the Disenable and Survivorship
insurance (D&S)
•
On January 2012 launch the
complementary
health
insurance
business,
adding
more than 15,000 beneficiaries
per month
601 47,428 (98.7%)
EBITDA**
**EBITDA calculated as profit before tax minus depreciation, finance cost and other non operational cost. *Exchange rate of Ch$507.16 as of June 30th,2013.
Vida Cámara: Key considerations
Since July 2012, Vida Cámara
stopped supplying the D&S
insurance
36% primus market share (July
2010-June 2012)
Complementary health insurance
Life and catastrophic insurance
Entrance in Peru
In average, more
than 15,000
beneficiaries per
month
Evolution of beneficiaries for the complementary health insurace
New projects
23
Financial Summary
Balance Sheet and Income Statement
Jun – 13 601,573 1,375,373 1,976,946 Dec – 12 667,003 1,414,397 2,081,400Balance
Total current assets Total non current assets
TOTAL ASSETS 264,377 560,553 824,930 342,770 622,548 965,318 Total current liabilities
Total non current liabilities
TOTAL LIABILITIES
1,152,016 1,116,082 TOTAL EQUITY
1,976,946 2,081,400 TOTAL EQUITY &
LIABILITIES Jun– 13 639,702 (422,600) 217,102 Jun – 12 730,065 (466,780) 263,285
Income Statement
Revenues Cost of sales Gross Profit (129,709) 89,804 (119,190) 144,908 SG&A. Operating Income 14,669 18,085Non Operating Income
58,938 107,583 NET INCOME
US$* Thousands
Jun– 13 38,651 330,108US$* Thousand
Short term debt Long term debt
368,759 Total financial debt
Jun – 13 130,167
1,152,016
US$* Thousand
Cash & cash equivalent
Total equity
< 1.0 X
0.21 x
COVENANT
Net Fin. Debt / Total Equity
*Exchange rate of Ch$507,16 as of June 30th, 2013
124,034 181,351
EBITDA**
**EBITDA calculated as profit before tax minus depreciation, finance cost, other non operational cost and financial income due to Habitat´s encaje.
25
ILC
Page 25
Financial Debt (USD
million) ILC Habitat Vida Cámara C. Machalí Consalud Red Salud TOTAL
Short Term
5.6
0.1
0.3
0.3
0.1
32.3
38.7
Bonds
0.6
-
-
-
-
-
0.6
Bank loans
4.9
-
0.3
0.3
0.1
14.0
19.6
Leasing in UF
-
0.1
-
-
-
18.4
18.5
Long Term
108.4
0.5
1.0
6.3
3.2
210.6
330.1
Bonds
108.4
-
-
-
-
87.8
196.3
Bank loans
-
-
1.0
6.3
3.2
39.7
50.2
Leasing in UF
-
0.5
-
-
-
83.1
83.6
Total
114.0
0.6
1.3
6.6
3.3
242.9
368.8
Financial Data (Jun-13)
Financial Debt
Cash Flow from main subsidiaries (Jun-13)
EBITDA Composition (Jun-13)
Credit Risk
Feller Rate:
AA+
Humphreys:
AA+
Local credit rating
*Exchange rate of Ch$507,16 as of June 30tth, 2013
46,302 42,458 8,763 4,314 10,512 11,955 24,054 305 2,343 3,873 0 10000 20000 30000 40000 50000 60000 70000 80000 90000 100000 1H12 1H13 Others Vida Cámara Red Salud Consalud Habitat Ch$ million
Jun-13
Distributable
Net Income
(Ch$ mm)
Dividend
Policiy** %
Ownership
%
Div. to ILC
(Ch$ mm)
Habitat
29,920
90%
67.5%
18,171
Red Salud
2,804
100%
89.9%
2,521
Consalud*
2,898
100%
99.9%
2,895
Vida Cámara
153
100%
99.9%
153
Total
35,774
23,739
Market Cap Composition* (Sep-13)
Market Cap (US$ mm)
P/E Ratio
ILC:
10.9x
Habitat:
10.4x
Healthcare & Others:
11.2 x
967 1,248 281 0 200 400 600 800 1,000 1,200 1,400
Habitat Healthcare & Others ILC